Abstract
Multicellular organisms are equipped with an intricate system to recognize and neutralize foreign and potentially dangerous components such as parasites, microorganisms, and neoplastic cells. However, many neoplastic tissues are capable of proliferative growth eventually leading to the death of the host, despite potential host antitumor cellular and humoral immunity. Inefficient antitumor activity is probably due to a complex series of events and factors that may include malfunction or suppression of host cells involved in antitumor responses and/or modification of tumor cells, for example, nonexpression or modification of antigenic determinants, inhibition of potential antitumor responses by antigen, sera, and/or tumor cell membrane complexes, accessibility of the tumor to components of the immune system, and a rate of tumor growth that outstrips the responses generated against it. An understanding of the characteristics, functions, and interactions of humoral and cellular host components involved in such responses might enable manipulation to benefit the individual.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allison, A.C., 1972, Immunity and immunopathology in virus infections, Ann. Inst. Pasteur, Paris 123: 585.
Amos, D. B., 1960, Possible relations between the cytotoxic effects of isoantibody and host cell function, Ann. N.Y. Acad. Sci. 87: 273.
Amos, D. B., 1962a, Host response to ascites tumors, in: Mechanism of Cell and Tissue Damage Produced by Immune Reactions, p. 210, Benno Schwabe and Co., Basel, Switzerland.
Amos, D. B., 1962b, The use of simplified systems as an aid to the interpretation of mechanisms of graft rejection, Prog. Allergy 6: 468.
Amos, D. B., and Wakefield, J. D., 1959, Growth of ascites tumor cells in diffusion chambers. II. Lysis and growth inhibition by diffusible isoantibody, J. Natl. Cancer Inst. 22: 1077.
Andersson, L. C., and Häyry, P., 1975, Clonal isolation of alloantigen-reactive T Cells and characterization of their memory, Transplant. Rev. 25: 121.
Baker, P., Weiser, R. S., Jutila, J., Evans, C. A., and Blandau, R. J., 1962, Mechanisms of tumor homograft rejection: The behavior of Sarcoma I ascites tumor in the A/Jax and C57BL/6K mouse, Ann. N.Y. Acad. Sci. 101: 46.
Berke, G., 1980, Interaction of cytotoxic T lymphocytes and target cells, Prog. Allergy 27: 69–133.
Berke, G., and Amos, D. B., 1973a, Mechanism of lymphocyte-mediated cytolysis: The LMC cycle and its role in transplantation, Transplant. Rev. 17: 71.
Berke, G., and Amos, D. B., 1973b, Cytotoxic lymphocytes in the absence of detectable antibody, Nature (London) New Biol. 242: 237.
Berke, G., Sullivan, K., and Amos, D. B., 1972, Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB/c mice immune to EL4 leukosis, J. Exp. Med. 135: 1334.
Berke, G., Gabison, D., and Feldman, M., 1975, The frequency of effector cells in populations containing cytotoxic T lymphocytes, Eur. J. Immunol. 5: 813.
Biddison, W. E., and Palmer, J. C., 1977, Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815, Proc. Nat. Acad. Sci. USA 74: 329.
Biddison, W. E., Palmer, J. C., Alexander, M. A., Cowan, E. P., and Manson, L. A., 1977, Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor, J. Immunol. 118: 2243.
Canty, T. G., and Wunderlich, J. R., 1971, Quantitative assessment of cellular and humoral responses to skin and tumor allografts, Transplantation 11: 111.
Cerottini, J. C., and Brunner, K. T., 1971, Cytotoxic lymphocytes as effector cells of cell-mediated immunity, in: Progress in Immunology, Vol. 1 ( D. B. Amos, ed.), p. 385, Academic Press, New York.
Cerottini, J. C., and Brunner, K. T., 1974, Cell-mediated cytotoxicity, allograft rejection and tumor immunity, Adv. Immunol. 18: 67.
Cerottini, J. C., Engers, H. D., MacDonald, H. R., and Brunner, K. T., 1974, Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures, J. Exp. Med. 140: 703.
Cohen, I. R., and Livnat, S., 1976, The cell-mediated immune response: Interactions of initiator and recruited T lymphocytes, Transplant. Rev. 29: 24.
Evans, R., 1972, Macrophages in syngeneic animal tumors, Transplantation 14: 468.
Evans, R., and Alexander, P., 1970, Cooperation of immune cells with macrophages in tumor immunity, Nature (London) 228: 620.
Ford, W. L.. 1975, Lymphocyte migration and immune responses, Prog. Allergy 19: 1.
Golstein, P., and Smith, E. T., 1977, Mechanism of T- cell-mediatedcytolysis: The lethal hit stage, in: Contemporary Topics in Immunobiology, Vol. 7 (0. Stutman, ed.), pp. 273–300, Plenum Press, New York.
Gorer, D., 1956, Some recent work on tumor immunity, Adv. Cancer Res. 4: 149.
Hashimoto, Y., and Sudo, H., 1968, Studies on acquired transplantation resistance. III. Cytocidal effect of sensitized peritoneal lymphocytic cells of Donryu rats against the target Yoshida sarcoma cells in vitro, Gann 59: 7.
Hashimoto, Y., Ishidate, M., and Takaku, M., 1965, Studies on acquired transplantation resistance. II. Action of peritoneal exudate cells of Donryu rats immune to the tumor against Yoshida sarcoma, Gann 56: 23.
Haskill, J. S., Häyry, P., and Radov, L. A., 1978, Systemic and local immunity in allograft and cancer rejection, in: Contemporary Topics in Immunobiology, Vol. 8 ( N. L. Warner and M. D. Cooper, eds.), pp. 107–170, Plenum Press, New York.
Hellström, K. E., and Hellström, I., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens, Adv. Immunol. 18: 209.
Henney, C. S., 1977, T- cell-mediatedcytolysis: An overview of some current issues, in: Contemporary Topics in Immunobiology, Vol. 7 (0. Stutman, ed.), pp. 245–272, Plenum Press, New York.
Herberman, R. B., 1974, Cell-mediated immunity to tumor cells, Adv. Cancer Res. 19: 207.
Herberman, R. B., Campbell, D. A., Oldham, R. K., Bonnard, G. D., Ting, C. C., Holden, H. T., Glaser, M., Djeu, J., and Oehler, R., 1976, Immunogenicity of tumor antigens, Ann. N.Y. Acad. Sci. 276: 26.
Johnson, T. S., Hudson, J. L., Feldman, M. E., and Irvin, G. L., 1975, Innumoprophylaxis and cytotoxic effector cells against EL4 leukemia induced in syngeneic C57BL/6J mice by use of irradiated EL4 cells, J. Natl. Cancer Inst. 55: 561.
Klein, E., and Klein, G., 1972, Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells, Cell. Immunol. 5: 201.
Klein, G., and Klein, E., 1956, Conversion of solid neoplasms into ascites tumors, Ann. N.Y. Acad. Sci. 63: 640.
Levy, M. H., Wheelock, E. F., 1974, The role of macrophages in defense against neoplastic diseases, Adv. Cancer Res. 20: 133.
Martz, E., 1977, Mechanism of specific tumor cell lysis by alloimmune T lymphocytes: Resolution and characterization of discrete steps in the cellular interaction, in: Contemporary Topics in Immunobiology, Vol. 7 (0. Stutman, ed.), pp. 301–361, Plenum Press, New York.
Nowotny, A., Groshsman, J., Abdelnoor, A., Rote, N., Yang, C., and Waltersdorff, R., 1974, Escape of TA3 tumors from allogeneic immune rejection: Theory and experiments, Eur. J. Immunol. 4: 73.
Old, L. J., Boyse, E. A., Bennet, B., and Lilly, F., 1963, Peritoneal cells as an immune population in transplantation studies, in: Cell-Bound Antibodies ( B. Amos and H. Koprovski, eds.), p. 89, Wistar Press, Philadelphia.
Patt, H. M., and Straube, R. L., 1956, Measurement and nature of ascites tumor growth, Ann. N.Y. Acad. Sci. 63: 728.
Pedersen, N. C., and Morris, B., 1970, The role of the lymphatic system in the rejection of homografts: A study of lymph from renal transplants, J. Exp. Med. 131: 936.
Raz, A., Goldman, R., Yuli, I., and Inbar, M., 1978, Isolation of plasma membrane fragments and vesicles from ascites fluid of lymphoma-bearing mice and their possible role in the escape mechanism of tumors from host immune rejection, Cancer Immunol. Immunother. 4: 53.
Roberts, P. J., and Häyry, P., 1977, Effector mechanism in allograft rejection. II. Density, electrophoresis, and size fractionation of allograft-infiltrating cells demonstrating several classes of killer cells, Cell. Immunol. 30: 326.
Russell, S. W., Doe, W. F., Hoskins, R. G., and Cochrane, C. G., 1976, Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells, Int. J. Cancer 18: 322.
Schick, B., and Berke, G., 1977a, Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells, J. Immunol. 118: 986.
Schick, B., and Berke, G., 1977b, Tumor-associated lymphoid cells: Analysis of host cells that bind to syngeneic and allogeneic tumor cells shortly after tumor administration, Transplant. Proc. 9: 1157.
Straube, R. L., Hill, M. S., and Patt, H. M., 1955, Vascular permeability and ascites tumor growth, Proc. Am. Assoc. Cancer Res. 2: 49.
Strom, T. B., Tilney, N. L., Paradysz, J. M., Bancewicz, J., and Carpenter, C. B., 1977, Cellular components of allograft rejection: Identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts, J. Immunol. 118: 2020.
Takasugi, M., and Klein, E., 1970, A microassay for cell-mediated immunity, Transplantation 9: 219.
Tracey, D. E., Pross, H. F., Jondal, M., and Witz, I. P., 1975, Antibody-dependent cell- mediated cytotoxic activity in syngeneic mouse ascites tumors, Int. J. Cancer 16: 870.
Van Blitterswijk, W. J., Emmelot, P., Hilkmann, H. A. M., Oomen-Meulemans, E. P. M., and Inbar, M., 1977, Differences in lipid fluidity among isolated plasma membranes of normal and leukemic lymphocytes and membranes exfoliated from their cell surface, Biochim. Biophys. Acta 467: 309.
Van Blitterswijk, W. J., Emmelot, P., Hilkmann, H. A., Hilgers, J., and Feltkamp, C. A., 1979, Rigid plasma-membrane-derived vesicles enriched in tumor associated surface antigens (MLr) occurring in the ascites-fluid of a murine leukemia (GRSL), Int. J. Cancer 23: 62.
Wagner, H., and Röllinghoff, M., 1973, In vitro induction of tumor-specific immunity. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors, J. Exp. Med. 138: 1.
Waksman, B. H., 1970, Atlas of Experimental Immunobiology and Immunopathology, Yale University Press, New Haven and London.
Waksman, B. H., 1974, The antiallograft response effector mechanism, in: Progress in Immunology, Vol. 5 ( L. Brent and E. J. Holbrow, eds.), p. 127, North-Holland, Amsterdam.
Weaver, J. M., 1958, Destruction of mouse ascites tumor cells in vivo and in vitro by homologous macrophages, lymphocytes, and cell-free antibodies, Proc. Am. Assoc. Cancer Res. 2: 354.
Wilson, D. B., and Billingham, R. E., 1967, Lymphocytes and transplantation immunity, Adv. Immunol. 7: 189.
Zbar, B., Wepsic, H. T., Borsos, T., and Rapp, H. J., 1970, Tumor-graft rejection in syngeneic guinea pigs, Evidence for a two-step mechanism, J. Natl. Cancer Inst. 44: 473.
Zettergren, J. G., Luberoff, D. E., and Pretlow, T. G., 1973, Separation of lymphocytes from disaggregated mouse malignant neoplasms by sedimentation in gradients of Ficoll in tissue culture medium, J. Immunol. 111: 836.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer Science+Business Media New York
About this chapter
Cite this chapter
Berke, G., Schick, B. (1980). Tumor Immunity in the Peritoneal Cavity. In: Witz, I.P., Hanna, M.G. (eds) In Situ Expression of Tumor Immunity. Contemporary Topics in Immunobiology, vol 10. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3677-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3677-8_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3679-2
Online ISBN: 978-1-4684-3677-8
eBook Packages: Springer Book Archive